Full name : Anand Rene
First name : Rene
Mail : LSU Medical Center - Neuroscience Center,2020 Gravier Street - Suite D,New Orleans, LA 70112
Zip Code :
City :
Country : USA
Email : ranand@lsumc.edu
Phone : I 504 599 0847
Fax : I 504 599 0891
Website :
Directory :
Comment
Title : A Phenotypic Screen Identifies Potent DPP9 Inhibitors Capable of Killing HIV-1 Infected Cells - Moore_2022_ACS.Chem.Biol_17_2595 |
Author(s) : Moore KP , Schwaid AG , Tudor M , Park S , Beshore DC , Converso A , Shipe WD , Anand R , Lan P , Moningka R , Rothman DM , Sun W , Chi A , Cornella-Taracido I , Adam GC , Bahnck-Teets C , Carroll SS , Fay JF , Goh SL , Lusen J , Quan S , Rodriguez S , Xu M , Andrews CL , Song C , Filzen T , Li J , Hollenstein K , Klein DJ , Lammens A , Lim UM , Fang Z , McHale C , Li Y , Lu M , Diamond TL , Howell BJ , Zuck P , Balibar CJ |
Ref : ACS Chemical Biology , 17 :2595 , 2022 |
Abstract : |
PubMedSearch : Moore_2022_ACS.Chem.Biol_17_2595 |
PubMedID: 36044633 |
Gene_locus related to this paper: human-DPP8 , human-DPP9 |
Title : Therapeutics of Alzheimer's disease: Past, present and future - Anand_2014_Neuropharmacol_76 Pt A_27 |
Author(s) : Anand R , Gill KD , Mahdi AA |
Ref : Neuropharmacology , 76 Pt A :27 , 2014 |
Abstract : |
PubMedSearch : Anand_2014_Neuropharmacol_76 Pt A_27 |
PubMedID: 23891641 |
Title : Nonhuman genetics. Genomic basis for the convergent evolution of electric organs - Gallant_2014_Science_344_1522 |
Author(s) : Gallant JR , Traeger LL , Volkening JD , Moffett H , Chen PH , Novina CD , Phillips GN, Jr. , Anand R , Wells GB , Pinch M , Guth R , Unguez GA , Albert JS , Zakon HH , Samanta MP , Sussman MR |
Ref : Science , 344 :1522 , 2014 |
Abstract : |
PubMedSearch : Gallant_2014_Science_344_1522 |
PubMedID: 24970089 |
Gene_locus related to this paper: eleel-BCHE , eleel-a0a4w4gcb7 , eleel-a0a4w4dt57 , eleel-a0a4w4es34 , eleel-a0a4w4duk0 |
Title : Presynaptic targeting of alpha4beta 2 nicotinic acetylcholine receptors is regulated by neurexin-1beta - Cheng_2009_J.Biol.Chem_284_23251 |
Author(s) : Cheng SB , Amici SA , Ren XQ , McKay SB , Treuil MW , Lindstrom JM , Rao J , Anand R |
Ref : Journal of Biological Chemistry , 284 :23251 , 2009 |
Abstract : |
PubMedSearch : Cheng_2009_J.Biol.Chem_284_23251 |
PubMedID: 19567877 |
Title : Mutations of cytosolic loop residues impair assembly and maturation of alpha7 nicotinic acetylcholine receptors - Mukherjee_2009_J.Neurochem_110_1885 |
Author(s) : Mukherjee J , Kuryatov A , Moss SJ , Lindstrom JM , Anand R |
Ref : Journal of Neurochemistry , 110 :1885 , 2009 |
Abstract : |
PubMedSearch : Mukherjee_2009_J.Neurochem_110_1885 |
PubMedID: 19627445 |
Title : Structural determinants of alpha4beta2 nicotinic acetylcholine receptor trafficking - Ren_2005_J.Neurosci_25_6676 |
Author(s) : Ren XQ , Cheng SB , Treuil MW , Mukherjee J , Rao J , Braunewell KH , Lindstrom JM , Anand R |
Ref : Journal of Neuroscience , 25 :6676 , 2005 |
Abstract : |
PubMedSearch : Ren_2005_J.Neurosci_25_6676 |
PubMedID: 16014729 |
Title : Impact of study design and patient population on outcomes from cholinesterase inhibitor trials - Anand_2003_Am.J.Geriatr.Psychiatry_11_160 |
Author(s) : Anand R , Hartman R , Sohn H , Danyluk J , Graham SM |
Ref : American Journal of Geriatry & Psychiatry , 11 :160 , 2003 |
Abstract : |
PubMedSearch : Anand_2003_Am.J.Geriatr.Psychiatry_11_160 |
PubMedID: 12611745 |
Title : A pilot, randomized, open-label trial assessing safety and pharmakokinetic parameters of co-administration of rivastigmine with risperidone in dementia patients with behavioral disturbances - Weiser_2002_Int.J.Geriatr.Psychiatry_17_343 |
Author(s) : Weiser M , Rotmensch HH , Korczyn AD , Hartman R , Cicin-Sain A , Anand R |
Ref : Int J Geriatr Psychiatry , 17 :343 , 2002 |
Abstract : |
PubMedSearch : Weiser_2002_Int.J.Geriatr.Psychiatry_17_343 |
PubMedID: 11994888 |
Title : Electrocardiographic effects of rivastigmine - Morganroth_2002_J.Clin.Pharmacol_42_558 |
Author(s) : Morganroth J , Graham S , Hartman R , Anand R |
Ref : Journal of Clinical Pharmacology , 42 :558 , 2002 |
Abstract : |
PubMedSearch : Morganroth_2002_J.Clin.Pharmacol_42_558 |
PubMedID: 12017350 |
Title : The calcium sensor protein visinin-like protein-1 modulates the surface expression and agonist sensitivity of the alpha 4beta 2 nicotinic acetylcholine receptor - Lin_2002_J.Biol.Chem_277_41872 |
Author(s) : Lin L , Jeanclos EM , Treuil M , Braunewell KH , Gundelfinger ED , Anand R |
Ref : Journal of Biological Chemistry , 277 :41872 , 2002 |
Abstract : |
PubMedSearch : Lin_2002_J.Biol.Chem_277_41872 |
PubMedID: 12202488 |
Title : Impact of Alzheimer's disease and rivastigmine treatment on activities of daily living over the course of mild to moderately severe disease - Potki_2002_Prog.Neuropsychopharmacol.Biol.Psychiatry_26_713 |
Author(s) : Potki SG , Anand R , Hartman R , Veach J , Grossberg G |
Ref : Prog Neuropsychopharmacol Biological Psychiatry , 26 :713 , 2002 |
Abstract : |
PubMedSearch : Potki_2002_Prog.Neuropsychopharmacol.Biol.Psychiatry_26_713 |
PubMedID: 12188104 |
Title : Barriers to drug discovery and development for Alzheimer disease - Fillit_2002_Alzheimer.Dis.Assoc.Disord_16 Suppl 1_S1 |
Author(s) : Fillit HM , O'Connell AW , Brown WM , Altstiel LD , Anand R , Collins K , Ferris SH , Khachaturian ZS , Kinoshita J , Van Eldik L , Dewey CF |
Ref : Alzheimer Disease & Associated Disorders , 16 Suppl 1 :S1 , 2002 |
Abstract : |
PubMedSearch : Fillit_2002_Alzheimer.Dis.Assoc.Disord_16 Suppl 1_S1 |
PubMedID: 12070355 |
Title : Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression - Farlow_2001_Arch.Neurol_58_417 |
Author(s) : Farlow MR , Hake A , Messina J , Hartman R , Veach J , Anand R |
Ref : Archives of Neurology , 58 :417 , 2001 |
Abstract : |
PubMedSearch : Farlow_2001_Arch.Neurol_58_417 |
PubMedID: 11255445 |
Title : Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease - Potkin_2001_Int.J.Neuropsychopharmacol_4_223 |
Author(s) : Potkin SG , Anand R , Fleming K , Alva G , Keator D , Carreon D , Messina J , Wu JC , Hartman R , Fallon JH |
Ref : Int J Neuropsychopharmacol , 4 :223 , 2001 |
Abstract : |
PubMedSearch : Potkin_2001_Int.J.Neuropsychopharmacol_4_223 |
PubMedID: 11602028 |
Title : An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors - Kumar_2000_Eur.J.Neurol_7_159 |
Author(s) : Kumar V , Anand R , Messina J , Hartman R , Veach J |
Ref : Eur Journal of Neurology , 7 :159 , 2000 |
Abstract : |
PubMedSearch : Kumar_2000_Eur.J.Neurol_7_159 |
PubMedID: 10809936 |
Title : A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease - Farlow_2000_Eur.Neurol_44_236 |
Author(s) : Farlow M , Anand R , Messina J, Jr. , Hartman R , Veach J |
Ref : Eur Neurol , 44 :236 , 2000 |
Abstract : |
PubMedSearch : Farlow_2000_Eur.Neurol_44_236 |
PubMedID: 11096224 |
Title : Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study - McKeith_2000_Lancet_356_2031 |
Author(s) : McKeith I , Del Ser T , Spano P , Emre M , Wesnes K , Anand R , Cicin-Sain A , Ferrara R , Spiegel R |
Ref : Lancet , 356 :2031 , 2000 |
Abstract : |
PubMedSearch : McKeith_2000_Lancet_356_2031 |
PubMedID: 11145488 |
Title : Lack of adverse pharmacodynamic drug interactions with rivastigmine and twenty-two classes of medications - Grossberg_2000_Int.J.Geriatr.Psychiatry_15_242 |
Author(s) : Grossberg GT , Stahelin HB , Messina JC , Anand R , Veach J |
Ref : Int J Geriatr Psychiatry , 15 :242 , 2000 |
Abstract : |
PubMedSearch : Grossberg_2000_Int.J.Geriatr.Psychiatry_15_242 |
PubMedID: 10713582 |
Title : Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial - Rosler_1999_BMJ_318_633 |
Author(s) : Rosler M , Anand R , Cicin-Sain A , Gauthier S , Agid Y , Dal-Bianco P , Stahelin HB , Hartman R , Gharabawi M |
Ref : BMJ , 318 :633 , 1999 |
Abstract : |
PubMedSearch : Rosler_1999_BMJ_318_633 |
PubMedID: 10066203 |
Title : A phase II study in patients with Alzheimer's disease to assess the preliminary efficacy and maximum tolerated dose of rivastigmine (Exelon) - Forette_1999_Eur.J.Neurol_6_423 |
Author(s) : Forette F , Anand R , Gharabawi G |
Ref : Eur Journal of Neurology , 6 :423 , 1999 |
Abstract : |
PubMedSearch : Forette_1999_Eur.J.Neurol_6_423 |
PubMedID: 10362894 |
Title : Determinants of channel gating located in the N-terminal extracellular domain of nicotinicalpha7 receptor - |
Author(s) : Anand R , Gerzanich V , Nelson ME , Wells GB , Lindstrom JM |
Ref : Journal de Physiologie (Paris) , 92 :403 , 1998 |
PubMedID: |
Title : Structure and function of neuronal nicotinic acetylcholine receptors - |
Author(s) : Lindstrom JM , Anand R , Gerzanich V , Peng X , Wang F , Wells G |
Ref : Prog Brain Res , 109 :125 , 1996 |
PubMedID: 9009699 |
Title : Safety\/tolerability trial of SDZ ENA 713 in patients with probable Alzheimer's disease - Sramek_1996_Life.Sci_58_1201 |
Author(s) : Sramek JJ , Anand R , Wardle TS , Irwin P , Hartman RD , Cutler NR |
Ref : Life Sciences , 58 :1201 , 1996 |
Abstract : |
PubMedSearch : Sramek_1996_Life.Sci_58_1201 |
PubMedID: 8614273 |